Wound News and Research

RSS

MDEA program is accepting entries for its 2010 competition

The Medical Design Excellence Awards (MDEA) program is accepting entries for its 2010 competition from companies and individuals worldwide involved in the design, engineering, manufacture, or distribution of finished medical devices or packaging products.

15 Oct 2009

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.

15 Oct 2009

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Smiths Detection today announces the award of a $1m, two-year grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a rapid test for eight micro-organisms that commonly cause burn/wound infections leading to septicemia (blood-poisoning).

14 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Covidien launches V-Loc absorbable wound closure device

Covidien, a leading global provider of healthcare products, today announced the global rollout of the V-Loc™ absorbable wound closure device, the first surgical device of its kind to feature unidirectional barbed technology that enables surgeons to close dermal wounds quickly and securely without tying knots.

13 Oct 2009

Systagenix Wound Management forms new global Medical Advisory Board

Systagenix Wound Management has announced the formation of a new global Medical Advisory Board, consisting of a group of multi-disciplinary and highly respected wound care clinicians and practitioners from North America and Europe, which will be led by Systagenix's newly appointed Medical Director, Dr Robert Snyder.

13 Oct 2009

Simple wound dressings versus antimicrobial dressings

The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases.

13 Oct 2009

Kinetic Concepts to showcase its ABThera OA NPT System at the American College of Surgeons Congress

Kinetic Concepts, Inc. will feature ABThera™ Open Abdomen Negative Pressure Therapy System, the latest addition to the KCI Negative Pressure Technology Platform (NPTP), at the American College of Surgeons’ 95th Annual Clinical Congress, Oct. 11-15 in Chicago.

13 Oct 2009

The third annual AdvaMed 2009: The MedTech Conference commences today

Leaders of the medical technology industry convene today through the 14th at the Walter E. Washington Convention Center for the third annual AdvaMed 2009: The MedTech Conference.

13 Oct 2009

VirtualHealth Technologies, Wound Care Innovations enter licensing agreement to use Cifra healthcare platform

VirtualHealth Technologies, Inc., a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today that its subsidiary Secure eHealth has entered into an agreement with Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies Inc., to use its Cifra secure healthcare platform.

12 Oct 2009

Cifra healthcare platform from Wound Management Technologies

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra(TM) healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx® products in managing all types of wound care.

12 Oct 2009

Researchers find how KEAP1 tumor suppressor works

A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.

12 Oct 2009

iMedicor to market Access Pharmaceuticals' MuGard in North America

ACCESS PHARMACEUTICALS, INC. announced today that it had signed an agreement with iMedicor for the North American commercial launch of MuGard, its FDA approved mucoadhesive oral rinse for the management of oral mucositis and stomatitis caused by radiotherapy and/or chemotherapy.

6 Oct 2009

DuraPrep solution effective against surgical-site infections

3M Health Care today announced the publication of a new independent study “Effects of Preoperative Skin Preparation on Postoperative Wound Infection Rates:

6 Oct 2009

Myocardial and neurological effects of Tβ4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on the results of several important research programs with Thymosin beta 4 (Tβ4) presented at the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

5 Oct 2009

New study reports PRP treatment and its use in sports medicine

Platelet -rich plasma (PRP) is currently used as an alternative treatment method for several common orthopaedic-related sports medicine conditions.

3 Oct 2009

Cardium announces positive results from the Phase 1 / 2 clinical study of Excellarate

Cardium Therapeutics announced plans to report on preliminary safety and efficacy data from its Matrix Phase 2b Excellarate clinical study. Based on guidance from Cardium's independent clinical data management company which is currently completing the statistical analysis of all data for the Matrix clinical trial, Cardium expects to receive the locked unblinded data set and be in position to announce preliminary results on or before October 14, 2009.

3 Oct 2009

Clinical study data of Thymosin beta 4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on several clinical studies with Thymosin beta 4 (Tβ4) presented the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

3 Oct 2009

Resorbable Orthopedics becomes wholly owned subsidiary of Wound Management Technologies

Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others.

1 Oct 2009

Acute therapy and follow-up care of burn disease discussed

Almost three quarters of patients with extensive burns die of the consequences of a severe infection. In the current edition of Deutsches Ärzteblatt International, Timo A. Spanholtz of the Cologne-Merheim Burn Center and his coauthors discuss the acute therapy and follow-up care of burn disease.

1 Oct 2009